Literature DB >> 29165486

Optical control of mitochondrial reductive reactions in living cells using an electron donor-acceptor linked molecule.

Yuta Takano1, Reina Munechika, Vasudevanpillai Biju, Hideyoshi Harashima, Hiroshi Imahori, Yuma Yamada.   

Abstract

It has been known for decades that intracellular redox reactions control various vital functions in living systems, which include the synthesis of biomolecules, the modulation of protein functions, and cell signaling. Although there have been several reports on the control of such functions using DNA and RNA, the non-invasive optical control of biological functions is an important ongoing challenge. In this study, a hybrid of an electron donor-acceptor linked molecule based on a ferrocene(Fc)-porphyrin(ZnP)-fullerene(C60) analogue and an elaborately designed nano-carrier, referred to herein as a MITO-Porter, resulted in a successful photoinduced intermolecular electron transfer reaction via the long-lived intramolecular charge separation, leading to site-specific reductive reactions in the mitochondria of living HeLa cells. A Fc-ZnP-C60 linked molecule, 1-Oct, was designed and prepared for taking advantage of the unique photophysical properties with excellent efficiency (i.e. a long lifetime and a high quantum yield) for photoinduced charge separation. The targeted delivery of 1-Oct to mitochondria was accomplished by using a combination of the Fc-ZnP-C60 molecule and a drug delivery nano-carrier, MITO-Porter, that was recently established by our group for intracellular cargo delivery. The successful delivery of 1-Oct by the MITO-Porter permitted the optically-controlled generation of O2- in the mitochondria of HeLa cells and the following induction of apoptosis as a cell signalling response was observed in confocal laser microscopy experiments. The obtained results indicate the use of an electron donor-acceptor system such as this can be a promising tool for the non-invasive triggering of redox-coupled cellular activities in living systems.

Entities:  

Year:  2017        PMID: 29165486     DOI: 10.1039/c7nr06310e

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  5 in total

1.  Validation of Gene Therapy for Mutant Mitochondria by Delivering Mitochondrial RNA Using a MITO-Porter.

Authors:  Eriko Kawamura; Minako Maruyama; Jiro Abe; Akira Sudo; Atsuhito Takeda; Shingo Takada; Takashi Yokota; Shintaro Kinugawa; Hideyoshi Harashima; Yuma Yamada
Journal:  Mol Ther Nucleic Acids       Date:  2020-04-19       Impact factor: 8.886

Review 2.  Challenges in Promoting Mitochondrial Transplantation Therapy.

Authors:  Yuma Yamada; Momo Ito; Manae Arai; Mitsue Hibino; Takao Tsujioka; Hideyoshi Harashima
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

3.  Validation of a mitochondrial RNA therapeutic strategy using fibroblasts from a Leigh syndrome patient with a mutation in the mitochondrial ND3 gene.

Authors:  Yuma Yamada; Kana Somiya; Akihiko Miyauchi; Hitoshi Osaka; Hideyoshi Harashima
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

Review 4.  Therapeutic Strategies for Regulating Mitochondrial Oxidative Stress.

Authors:  Yuma Yamada; Yuta Takano; Jiro Abe; Mitsue Hibino; Hideyoshi Harashima
Journal:  Biomolecules       Date:  2020-01-05

Review 5.  Evolution of drug delivery system from viewpoint of controlled intracellular trafficking and selective tissue targeting toward future nanomedicine.

Authors:  Yuma Yamada; Yusuke Sato; Takashi Nakamura; Hideyoshi Harashima
Journal:  J Control Release       Date:  2020-09-08       Impact factor: 9.776

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.